Literature DB >> 2897031

Cyclosporin metabolites and central-nervous-system toxicity.

U Kunzendorf, J Brockmöller, F Jochimsen, F Keller, G Walz, G Offermann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2897031     DOI： 10.1016/s0140-6736(88)92037-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  10 in total

1.  Incapacitating lower limb pain syndrome in cord blood stem cell transplant recipients with calcineurin inhibitor.

Authors:  Aiko Kida; Kazuteru Ohashi; Takeshi Kobayashii; Miwa Sakai; Takuya Yamashita; Hideki Akiyama; Shuji Kishida; Hisashi Sakamaki
Journal:  Pathol Oncol Res       Date:  2004-12-27       Impact factor: 3.201

2.  Cyclosporin neurotoxicity in cardiac transplant recipients.

Authors:  R J Lane; S W Roche; A A Leung; A Greco; L S Lange
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-11       Impact factor: 10.154

3.  Ciclosporin metabolite pattern in blood and urine of kidney graft patients in relation to liver function.

Authors:  J S Bleck; H J Schlitt; U Christians; R Schottmann; C Thiesemann; S Strohmeyer; K Kohlhaw; K Wonigeit; R Pichlmayr; K F Sewing
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 4.  The use of other drugs to allow a lower dosage of cyclosporin to be used. Therapeutic and pharmacoeconomic considerations.

Authors:  T E Jones
Journal:  Clin Pharmacokinet       Date:  1997-05       Impact factor: 6.447

5.  Complex partial status epilepticus associated with cyclosporin A therapy.

Authors:  R E Appleton; K Farrell; P Teal; S A Hashimoto; P K Wong
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-09       Impact factor: 10.154

6.  Quantitative MR diffusion mapping and cyclosporine-induced neurotoxicity.

Authors:  S C Coley; D A Porter; F Calamante; W K Chong; A Connelly
Journal:  AJNR Am J Neuroradiol       Date:  1999-09       Impact factor: 3.825

7.  Unusual cyclosporin related neurological complications in recipients of liver transplants.

Authors:  M R Cilio; O Danhaive; J F Gadisseux; J B Otte; E M Sokal
Journal:  Arch Dis Child       Date:  1993-03       Impact factor: 3.791

8.  Ciclosporin metabolite pattern in blood and urine of liver graft recipients. I. Association of ciclosporin metabolites with nephrotoxicity.

Authors:  U Christians; K Kohlhaw; J Budniak; J S Bleck; R Schottmann; H J Schlitt; V M Almeida; M Deters; K Wonigeit; R Pichlmayr
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

9.  Central neurotoxicity of cyclosporine in two children with nephrotic syndrome.

Authors:  Sophie Taque; Sylviane Peudenier; Sophie Gie; Marc Rambeau; Virginie Gandemer; Laure Bridoux; Pierre Bétrémieux; Loic De Parscau; Edouard Le Gall
Journal:  Pediatr Nephrol       Date:  2004-02-03       Impact factor: 3.714

Review 10.  A review of assay methods for cyclosporin. Clinical implications.

Authors:  K T Kivistö
Journal:  Clin Pharmacokinet       Date:  1992-09       Impact factor: 6.447
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.